Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs
Source: The Guardian ·
World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcoholHeineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – can…
From the source
Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider. The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – can reduce the desire to drink alcohol, which could lead to “fullness and fewer serves” of pints in pubs and bars. The document, revealed by Reuters, warned that the GLP-1 era could lead to the tradition of the multi-pint drinking session becoming a less frequent occurrence. The Netherlands-headquartered company offered advice including promoting half pints, low- and zero-alcohol options and pairing drinks with small plates of food, or risk declines in customer visits and spending. GLP-1 use has soared as consumers seek a quick, easy solution to rapid weight loss, with 10 million people turning to medication in the US last year, according to research by JP Morgan. Heineken, the world’s…